Cargando…

Sitagliptin and risk of heart failure hospitalization in patients with type 2 diabetes on dialysis: A population-based cohort study

The incidence of heart failure hospitalization (HHF) after taking sitagliptin in type 2 diabetes (T2DM) patients with end stage renal disease (ESRD) on dialysis is unclear. In this population-based cohort study, we identified individuals with T2DM and ESRD on dialysis who were treated with sitaglipt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hung, Yi-Chih, Lin, Che-Chen, Huang, Wei-Lun, Chang, Man-Ping, Chen, Ching-Chu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962317/ https://www.ncbi.nlm.nih.gov/pubmed/27460913 http://dx.doi.org/10.1038/srep30499

Ejemplares similares

Sitagliptin and heart failure hospitalization in patients with type 2 diabetes
por: Tseng, Chin-Hsiao
Publicado: (2016)

Association of Mean and Variability of HbA1c with Heart Failure in Patients with Type 2 Diabetes
por: Lin, You-Ting, et al.
Publicado: (2021)

The durability of sitagliptin in elderly patients with type 2 diabetes
por: Hsieh, Ching-Jung, et al.
Publicado: (2014)

Elevated Glycemic Gap Predicts Acute Respiratory Failure and In-hospital Mortality in Acute Heart Failure Patients with Diabetes
por: Liao, Wen-I, et al.
Publicado: (2019)

Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats
por: Sharma, Ashish Kumar, et al.
Publicado: (2012)

Sitagliptin does not reduce the risk of cardiovascular death or hospitalization for heart failure following myocardial infarction in patients with diabetes: observations from TECOS
por: Nauck, Michael A., et al.
Publicado: (2019)

Cardiovascular Outcomes of Sitagliptin in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Population-Based Cohort Study in Taiwan
por: Wang, Szu-Heng, et al.
Publicado: (2015)

Increased the risk of heart failure and comorbidities in patients with gout treatment: a population-based cohort study
por: Chen, Hsin-Hung, et al.
Publicado: (2020)

Epidemiology and Mortality of New-Onset Diabetes After Dialysis: Taiwan national cohort study
por: Tien, Kai-Jen, et al.
Publicado: (2013)

Sitagliptin After Ischemic Stroke in Type 2 Diabetic Patients: A Nationwide Cohort Study
por: Chen, Dong-Yi, et al.
Publicado: (2015)

Sitagliptin and Fractures in Type 2 Diabetes: A Nationwide Population-Based Propensity-Matching Study
por: Lin, Shih-Yi, et al.
Publicado: (2018)

Effect of sitagliptin on proteinuria in patients with type 2 diabetes – A renoprotective effect of sitagliptin
por: Narimani, Rouhollah, et al.
Publicado: (2021)

Comparative safety and effectiveness of sitagliptin in patients with type 2 diabetes: retrospective population based cohort study
por: Eurich, D T, et al.
Publicado: (2013)

Does Sitagliptin Affect the Rate of Osteoporotic Fractures in Type 2 Diabetes? Population-Based Cohort Study
por: Majumdar, Sumit R., et al.
Publicado: (2016)

Bidirectional association between ESRD dialysis and diabetes: National cohort study
por: Chu, Yeh-Wen, et al.
Publicado: (2017)

Cardiovascular risk of sitagliptin in ischemic stroke patients with type 2 diabetes and chronic kidney disease: A nationwide cohort study
por: Liang, Chung-Yu, et al.
Publicado: (2018)

The aging burden of hospitalization for heart failure in Chinese populations: evidence from the Macao Heart Failure Study
por: LU, Zhi-Nan, et al.
Publicado: (2020)

Epidemiology and outcomes of hypoglycemia in patients with advanced diabetic kidney disease on dialysis: A national cohort study
por: Chu, Yeh-Wen, et al.
Publicado: (2017)

Impact of heart failure and dialysis in the prognosis of diabetic patients with ischemic foot ulcers
por: Meloni, Marco, et al.
Publicado: (2018)

The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The CANA‐HF study
por: Carbone, Salvatore, et al.
Publicado: (2020)

Associations Between Using Chinese Herbal Medicine and Long-Term Outcome Among Pre-dialysis Diabetic Nephropathy Patients: A Retrospective Population-Based Cohort Study
por: Guo, Jenny Chun-Ling, et al.
Publicado: (2021)

The impact of comorbidity on survival after hemorrhagic stroke among dialysis patients: a nationwide population-based study
por: Lin, Chun-Yu, et al.
Publicado: (2014)

Long-Term Outcomes and Risk Factors of Renal Failure Requiring Dialysis after Heart Transplantation: A Nationwide Cohort Study
por: Wang, Tsai-Jung, et al.
Publicado: (2020)

Peritoneal Dialysis or Haemodialysis for Kidney Failure?
por: Man Shrestha, Badri
Publicado: (2018)

Health policies on dialysis modality selection: a nationwide population cohort study
por: Lin, Yi-Chun, et al.
Publicado: (2017)

Peritoneal dialysis as therapeutic option in heart failure patients
por: Grossekettler, Leonie, et al.
Publicado: (2019)

Prognostic nomogram for elderly patients with acute respiratory failure receiving invasive mechanical ventilation: a nationwide population-based cohort study in Taiwan
por: Hsu, Chun-Hsiang, et al.
Publicado: (2020)

The risk of hospitalization and modality failure with home dialysis
por: Suri, Rita S, et al.
Publicado: (2015)

Sitagliptin-induced hemolysis
por: Bekur, Ragini, et al.
Publicado: (2010)

Sitagliptin-Associated Angioedema
por: Gosmanov, Aidar R., et al.
Publicado: (2012)

Comparison of the efficacy of sitagliptin and glimepiride dose‐up in Japanese patients with type 2 diabetes poorly controlled by sitagliptin and glimepiride in combination
por: Shimoda, Seiya, et al.
Publicado: (2013)

Diabetes Mellitus and Heart Failure
por: Siao, Wun-Zhih, et al.
Publicado: (2022)

Transitions of dialysis status and outcomes after the unplanned first dialysis: a nationwide population-based cohort study
por: Liao, Chia-Te, et al.
Publicado: (2023)

The New Comorbidity Index for Predicting Survival in Elderly Dialysis Patients: A Long-Term Population-Based Study
por: Kan, Wei-Chih, et al.
Publicado: (2013)

Impact of kidney size on mortality in diabetic patients receiving peritoneal dialysis
por: Chen, Chun-Hao, et al.
Publicado: (2021)

New combination treatments in the management of diabetes: focus on sitagliptin – metformin
por: Green, Jennifer, et al.
Publicado: (2008)

Sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus
por: Miller, Shannon A, et al.
Publicado: (2009)

Sitagliptin Successfully Ameliorates Glycemic Control in Werner Syndrome With Diabetes
por: Kitamoto, Takumi, et al.
Publicado: (2012)

Sitagliptin improves albuminuria in patients with type 2 diabetes mellitus
por: Mori, Hiroko, et al.
Publicado: (2013)

Efficacy and Safety of Sitagliptin in Japanese Patients With Type 2 Diabetes
por: Ohmura, Hirotoshi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_o4loedjg01usrg5m809ne5si6u